Market Closed

IMVT
Immunovant
$ 34.18
-2.48%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Immunovant News

Latest Immunovant Stock News & IMVT Headlines

Does Immunovant (IMVT) Have the Potential to Rally 30.52% as Wall Street Analysts Expect?
3 days ago | zacks.com
Don't Fight The Momentum: Roivant Has Big Expectations, But Real Pipeline Momentum
3 days ago | seekingalpha.com
Immunovant (IMVT) Upgraded to Buy: Here's What You Should Know
3 days ago | zacks.com
Immunovant, Inc. (IMVT) Q2 2027 Earnings Call Transcript
5 days ago | seekingalpha.com
Immunovant Meets Primary Endpoint In Difficult-To-Treat Rheumatoid Arthritis Study
5 days ago | benzinga.com
What Immunovant (IMVT) Said on Its Q2 Earnings Call
5 days ago | marketbeat.com
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update
6 days ago | globenewswire.com
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
25 days ago | globenewswire.com
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
a month ago | gurufocus.com
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
a month ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

IMVT
Immunovant
$ 34.18
-2.48%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago